Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7900
+0.0169 (2.19%)
At close: Oct 24, 2025, 4:00 PM EDT
0.7604
-0.0296 (-3.75%)
After-hours: Oct 24, 2025, 7:43 PM EDT

Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $40.94 million. The enterprise value is -$73.04 million.

Market Cap40.94M
Enterprise Value -73.04M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

XLO has 51.83 million shares outstanding. The number of shares has increased by 17.92% in one year.

Current Share Class 51.83M
Shares Outstanding 51.83M
Shares Change (YoY) +17.92%
Shares Change (QoQ) -30.62%
Owned by Insiders (%) 14.04%
Owned by Institutions (%) 16.69%
Float 23.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.73
Forward PS 0.99
PB Ratio 5.79
P/TBV Ratio 5.79
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 1.07.

Current Ratio 2.32
Quick Ratio 2.28
Debt / Equity 1.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -47.21

Financial Efficiency

Return on equity (ROE) is -277.74% and return on invested capital (ROIC) is -124.80%.

Return on Equity (ROE) -277.74%
Return on Assets (ROA) -31.66%
Return on Invested Capital (ROIC) -124.80%
Return on Capital Employed (ROCE) -70.33%
Revenue Per Employee $234,391
Profits Per Employee -$878,469
Employee Count64
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -8.14% in the last 52 weeks. The beta is -0.05, so XLO's price volatility has been lower than the market average.

Beta (5Y) -0.05
52-Week Price Change -8.14%
50-Day Moving Average 0.75
200-Day Moving Average 0.78
Relative Strength Index (RSI) 53.55
Average Volume (20 Days) 475,706

Short Selling Information

The latest short interest is 5.16 million, so 9.96% of the outstanding shares have been sold short.

Short Interest 5.16M
Short Previous Month 4.92M
Short % of Shares Out 9.96%
Short % of Float 21.92%
Short Ratio (days to cover) 5.73

Income Statement

In the last 12 months, XLO had revenue of $15.00 million and -$56.22 million in losses. Loss per share was -$1.08.

Revenue15.00M
Gross Profit 13.02M
Operating Income -56.65M
Pretax Income -56.22M
Net Income -56.22M
EBITDA -55.02M
EBIT -56.65M
Loss Per Share -$1.08
Full Income Statement

Balance Sheet

The company has $121.55 million in cash and $7.57 million in debt, giving a net cash position of $113.99 million or $2.20 per share.

Cash & Cash Equivalents 121.55M
Total Debt 7.57M
Net Cash 113.99M
Net Cash Per Share $2.20
Equity (Book Value) 7.07M
Book Value Per Share 0.14
Working Capital 70.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.33 million and capital expenditures -$438,000, giving a free cash flow of -$13.77 million.

Operating Cash Flow -13.33M
Capital Expenditures -438,000
Free Cash Flow -13.77M
FCF Per Share -$0.27
Full Cash Flow Statement

Margins

Gross Margin 86.80%
Operating Margin -377.63%
Pretax Margin -374.79%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.92%
Shareholder Yield -17.92%
Earnings Yield -137.31%
FCF Yield -33.62%

Analyst Forecast

The average price target for XLO is $3.00, which is 279.75% higher than the current price. The consensus rating is "Buy".

Price Target $3.00
Price Target Difference 279.75%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) -15.63%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

XLO has an Altman Z-Score of -4.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.78
Piotroski F-Score 4